Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland, Gregory Kaltsas, Wouter W. de Herder
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 371-403
Open Access | Times Cited: 162

Showing 26-50 of 162 citing articles:

Primary hepatic neuroendocrine tumor with a suspicious pulmonary nodule: A case report and literature review
Haiyan Lv, M. Y. Liu, Hong Wang, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Rare epithelial gastric cancers: a review of the current treatment knowledge
Angelica Petrillo, Margaret Ottaviano, Luca Pompella, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Pancreatic Neuroendocrine Tumors—Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report
Simona Georgiana Popa, Andreea Loredana Golli, Cristina Matei, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 337-337
Open Access
A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors
Pablo Mata-Martínez, Lucía Celada, Francisco J. Cueto, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Research process of PET tracers for neuroendocrine tumors diagnosis
Xiangyuan Bao, Shuai Li, Shaobo Yao, et al.
American Journal of Nuclear Medicine and Molecular Imaging (2025) Vol. 15, Iss. 1, pp. 1-14
Closed Access
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
European Journal of Cancer (2025), pp. 115398-115398
Closed Access
Gastrointestinal neuroendocrine tumor syndromes (GI-NETS)
Tetsuhide Ito, Robert T. Jensen
Elsevier eBooks (2025)
Closed Access
Overview of the histopathological and immunohistochemical characteristics of neuroendocrine neoplasms
Sonia L. El-Sharkawy, Manal Badawi, Wafaa E. Abdelaal, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2025) Vol. 49, Iss. 1
Open Access
Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study
Manal S. Fawzy, Awwad Alenezy, Jessan A. Jishu, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1593-1593
Open Access
Broadening perspectives on hypoglycemia diagnosis in non-diabetic patients
Beatriz Rodríguez Jiménez, Ignacio Jiménez Varo, Francisco Órtega Ruiz, et al.
Endocrinología Diabetes y Nutrición (2025), pp. 501599-501599
Open Access
Carcinoid heart disease – Still a challenging diagnosis?
Laura Cătălina Benchea, Larisa Anghel, Radu Andy Sascău, et al.
Romanian Journal of Cardiology (2025)
Open Access
Currently available treatment options for neuroendocrine liver metastases
Nikolaos Machairas
Annals of Gastroenterology (2021)
Open Access | Times Cited: 21
Molecular Imaging of Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2662-e2670
Open Access | Times Cited: 16
Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms
Andrew Canakis, Linda Lee
World Journal of Gastrointestinal Endoscopy (2022) Vol. 14, Iss. 5, pp. 267-290
Open Access | Times Cited: 16
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
Michele Bevere, Αναστάσιος Γκουντάκος, Filippo Maria Martelli, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 303-303
Open Access | Times Cited: 9
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
Simron Singh, Diego Ferone, Jaume Capdevila, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature
Tiziana Feola, Giulia Puliani, Franz Sesti, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
Rashmi G. Shah, Marine A. Merlin, Samuel Adant, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 20
Chemotherapy in NEN: still has a role?
Paula Espinosa-Olarte, Anna La Salvia, María Carmen Riesco Martínez, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 595-614
Open Access | Times Cited: 19
Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort
Kirstie Lithgow, Hema Venkataraman, Steven J. Hughes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women
Anela Blažević, Anand M. Iyer, Marie‐Louise F. van Velthuysen, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 5, pp. e1969-e1975
Open Access | Times Cited: 14
Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging
Julie Refardt, Wouter T. Zandee, Tessa Brabander, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 11, pp. 615-624
Closed Access | Times Cited: 20
DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo
Thom G. A. Reuvers, Nicole S. Verkaik, Debra Stuurman, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3117-3130
Open Access | Times Cited: 7
Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms
Johannes Hofland, Wouter W. de Herder
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 5, pp. 101787-101787
Open Access | Times Cited: 7
Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
Malik Alwindi, Ariege Bizanti
Heliyon (2023) Vol. 9, Iss. 11, pp. e22413-e22413
Open Access | Times Cited: 7

Scroll to top